§ 20-13-1801. Title

This subchapter shall be known and may be cited as the “Naloxone Access Act”.

§ 20-13-1802. Legislative findings

The General Assembly finds that: (1) Naloxone is a relatively inexpensive opioid antagonist developed to counter the effects of opiate overdose, specifically the life-threatening depression of the central nervous and respiratory systems; (2) Naloxone will not adversely affect the human body if the person who receives Naloxone is suffering from an overdose of a drug […]

§ 20-13-1803. Definitions

As used in this subchapter: (1) “Emergency medical services technician” means an individual licensed by the Department of Health at any level established by the rules adopted by the State Board of Health under § 20-13-301 et seq. and authorized to perform emergency medical services, including without limitation an EMT, Advanced EMT, paramedic, EMS Instructor, […]

§ 20-13-1804. Opioid antagonist — Immunity

(a) A healthcare professional acting in good faith may directly or by standing order prescribe and dispense an opioid antagonist to: (1) A person at risk of experiencing an opioid-related drug overdose; (2) A pain management clinic; (3) A harm reduction organization; (4) An emergency medical services technician; (5) A first responder; (6) A law […]